JavaScript must be enabled in order for you to fully use this site. However, it seems JavaScript is either disabled or not supported by your browser. To use this site, enable JavaScript by changing your browser options, then try again.
More
Black Hills Regional Eye Institute Toll Free: Click For Map & Directions
Ranibizumab (Lucentis) for treating submacular vascularized pigment epithelial detachments – A prospective pilot study.
Candidates for this study include those with vascularized pigment epithelial detachments.